Company Overview of PhaseRx, Inc.
PhaseRx, Inc., an RNAi delivery technology company, develops a polymer-based system that enables the systemic delivery of RNAi-based drugs and other macromolecules as therapeutic products. Its PhaseRx polymer system delivers RNAi molecules into the cytoplasm where they can reach and inhibit the desired target of interest. PhaseRx, Inc. was incorporated in 2006 and is based in Seattle, Washington.
410 West Harrison Street
Seattle, WA 98119
Founded in 2006
Key Executives for PhaseRx, Inc.
PhaseRx, Inc. Key Developments
Similar Private Companies By Industry
|Vaxart, Inc.||United States|
|NaniRx Therapeutics, Inc.||United States|
|Biogen Idec MA Inc.||United States|
|MuciMed, Inc.||United States|
|GeneExcel, Inc.||United States|
Recent Private Companies Transactions
December 4, 2013
September 19, 2013
To contact PhaseRx, Inc., please visit www.phaserx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.